Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features

[1]  R. Ghossein,et al.  Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): An Update , 2020, Head and Neck Pathology.

[2]  A. Proietti,et al.  Noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP): a new entity. , 2020, Gland surgery.

[3]  I. Ganly,et al.  How many papillae in conventional papillary carcinoma? , 2019, Thyroid : official journal of the American Thyroid Association.

[4]  Bin Xu,et al.  Molecular Alterations in Thyroid Carcinoma. , 2019, Surgical pathology clinics.

[5]  S. Dasgupta.  Mitochondrion: I am more than a fuel server. , 2019, Annals of translational medicine.

[6]  V. Seshan,et al.  Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes. , 2018, Cancer cell.

[7]  A. Tischler,et al.  The evolving diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). , 2018, Human pathology.

[8]  Michelle N Wurst,et al.  Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth. , 2018, Archives of pathology & laboratory medicine.

[9]  M. Schlumberger,et al.  Noninvasive follicular thyroid neoplasm with papillary-like nuclear features , 2017, Current opinion in endocrinology, diabetes, and obesity.

[10]  R. Lloyd,et al.  WHO classification of tumours of endocrine organs , 2017 .

[11]  S. Devesa,et al.  Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 , 2017, JAMA.

[12]  G. Tallini,et al.  Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. , 2017, Thyroid : official journal of the American Thyroid Association.

[13]  M. Berger,et al.  The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform , 2017, JAMA oncology.

[14]  A. Tischler,et al.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. , 2016, JAMA oncology.

[15]  L. Thompson.  Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment , 2016, Modern Pathology.

[16]  V. Seshan,et al.  FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing , 2016, Nucleic acids research.

[17]  I. Ganly,et al.  Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant. , 2015, Human pathology.

[18]  Donavan T. Cheng,et al.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.

[19]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.

[20]  J. Lubin,et al.  The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. , 2014, The Journal of clinical endocrinology and metabolism.

[21]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[22]  N. Socci,et al.  Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. , 2013, The Journal of clinical endocrinology and metabolism.

[23]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[24]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[25]  J. Ricarte-Filho,et al.  Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns , 2010, Modern Pathology.

[26]  E. Bonora,et al.  Molecular features of thyroid oncocytic tumors , 2010, Molecular and Cellular Endocrinology.

[27]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[28]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[29]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[30]  J. Shah,et al.  Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). , 2009, Thyroid : official journal of the American Thyroid Association.

[31]  Giovanni Romeo,et al.  Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors , 2007, Proceedings of the National Academy of Sciences.

[32]  N. Katabi,et al.  Follicular variant of papillary thyroid carcinoma , 2006, Cancer.

[33]  E. Bonora,et al.  Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. , 2006, Cancer research.

[34]  Dillwyn Williams,et al.  Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid , 2005, British Journal of Cancer.

[35]  Q. Duh,et al.  Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence. , 2002, The Journal of clinical endocrinology and metabolism.

[36]  D. Ward,et al.  Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[37]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[38]  R. Hruban,et al.  Follicular variant of papillary thyroid carcinoma. A clinicopathologic study , 1994, Cancer.

[39]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[40]  O. Mundler,et al.  Late Recurrences of Thyroid Carcinoma 24 Years after a Complete Remission: When Monitoring Should be Stopped? , 2012, World journal of nuclear medicine.